Skip to search formSkip to main contentSkip to account menu

SB 200646A

Known as: SB-200646A, SKB-200646A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Effect of Combined Administration of Afobazole and 5-HT2b/2c Receptor Antagonist SB-200646A on Neurochemical Profile of Brain Structures in C57Bl/6 and BALB/c Mice
The effects of combined administration of afobazole and 5-НТ2b/2c receptor antagonist SB-200646A on the content of monoamines and… 
2011
2011
[Possible role of serotonin 5-HT2 receptors in mechanism of afobazole anxiolytic action: neurochemical study of inter-line differences in mice].
Effects of separate and combined introduction of afobazole and SB-200646A (highly selective 5-HT2B/2C receptor antagonist) on the… 
2006
2006
The acute and chronic administration of the 5‐HT2B/2C receptor antagonist SB‐200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo…
This study examined the effect of the acute and chronic administration of the 5‐HT2B/2C receptor antagonist N‐(1‐methyl‐5‐indolyl… 
Highly Cited
1998
Highly Cited
1998
The role of 5-HT2C receptors in affective disorders.
5-HT(2C) receptors are predominantly localised in the brain and their dysregulation may contribute to particular symptoms of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)